Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Abstract

Mucopolysaccharidoses (MPS) are disorders characterized by impaired glycosaminoglycan (GAG) catabolism as a consequence of a deficiency or the absence of lysosomal enzymes directly involved in their degradation. Multiple organ systems are involved in MPS, including the cardiovascular system. Recently, aortic root dilatation (ARD) has been described in these patients. Thus, we reviewed aortic root diameter measurements in 69 MPS patients from a single center from 2000 to 2016. Aortic root diameter z scores were calculated based on data published by Colan et al. according to the body surface area (BSA) determined using the Haycock formula. The overall incidence of ARD in MPS patients was 39.1%. Higher mean z scores were present in patients with MPS IVA and VI when compared to MPS I and II. Aortic root z scores were higher in older MPS IVA patients, which may suggest a progressive ARD change in this MPS type. No significant differences were found before and after enzyme replacement therapy (ERT) in 11 patients with available data (2 with MPS I; 4 with MPS II; 2 with MPS IVA, and 3 with MPS VI). This work provides further evidence that ARD is common in different types of MPS, being especially evident in MPS IVA, but with a significant occurrence also in MPS VI.

• Authors: Fabiano de Oliveira Poswar, Carolina Fischinger Moura de Souza, Roberto Giugliani, Guilherme Baldo
• Journal: Heart and vessels (Heart Vessels) Vol. 34 Issue 2 Pg. 290-295 (Feb 2019) ISSN: 1615-2573 [Electronic] Japan
• PMID: 30136169 (Publication Type: Journal Article)

Topics

• Adolescent
• Aortic Dissection (diagnosis, etiology)
• Aorta, Thoracic (diagnostic imaging)
• Aortic Aneurysm, Thoracic (diagnosis, etiology)
• Echocardiography
• Enzyme Replacement Therapy (methods)
• Female
• Follow-Up Studies
• Humans
• Male
• Mucopolysaccharidoses (complications, drug therapy)
• Time Factors